Abrdn PLC Vertex Pharmaceuticals Inc Transaction History

Abrdn PLC

$57.3 Billion
Q2 2025

A detailed history of Abrdn PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Abrdn PLC holds 287,967 shares of VRTX stock, worth $108 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

287,967

Previous 304,714 5.5%

Holding current value

$108 Million

Previous $148 Million 13.22%

% of portfolio

0.22%

Previous 0.29%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$421.16 - $509.5 $7.05 Million - $8.53 Million	-16,747 Reduced 5.5%	287,967 $128 Million
Q1 2025 May 13, 2025	SELL	$402.49 - $513.76 $17.2 Million - $22 Million	-42,856 Reduced 12.33%	304,714 $148 Million
Q4 2024 Jan 24, 2025	SELL	$396.64 - $516.74 $9.33 Million - $12.2 Million	-23,519 Reduced 6.34%	347,570 $140 Million
Q3 2024 Oct 24, 2024	SELL	$460.0 - $505.78 $143,980 - $158,309	-313 Reduced 0.08%	371,089 $173 Million
Q2 2024 Aug 09, 2024	SELL	$392.81 - $485.53 $79.7 Million - $98.5 Million	-202,795 Reduced 35.32%	371,402 $174 Million
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $2.78 Million - $3.04 Million	-6,821 Reduced 1.17%	574,197 $240 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $132 Million - $158 Million	384,730 Added 196.0%	581,018 $236 Million
Q3 2023 Nov 06, 2023	SELL	$338.18 - $362.46 $283,056 - $303,379	-837 Reduced 0.42%	196,288 $68.3 Million
Q2 2023 Jun 20, 2024	SELL	$314.42 - $351.91 $553,379 - $619,361	-1,760 Reduced 0.88%	197,125 $69.4 Million
Q2 2023 Aug 04, 2023	SELL	$314.42 - $351.91 $553,379 - $619,361	-1,760 Reduced 0.88%	197,125 $69.4 Million
Q1 2023 Jun 20, 2024	BUY	$283.23 - $323.1 $4.27 Million - $4.87 Million	15,069 Added 8.2%	198,885 $62.7 Million
Q1 2023 Apr 28, 2023	BUY	$283.23 - $323.1 $4.27 Million - $4.87 Million	15,069 Added 8.2%	198,885 $62.7 Million
Q4 2022 Jun 20, 2024	SELL	$285.76 - $321.48 $112 Million - $125 Million	-390,381 Reduced 67.99%	183,816 $53.1 Million
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $856,994 - $964,118	-2,999 Reduced 1.61%	183,816 $53.1 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $22.1 Million - $24.7 Million	80,841 Added 76.28%	186,815 $54.1 Million
Q2 2022 Aug 05, 2022	BUY	$234.96 - $292.55 $2.25 Million - $2.81 Million	9,591 Added 9.95%	105,974 $29.8 Million
Q1 2022 May 04, 2022	BUY	$221.42 - $260.97 $389,699 - $459,307	1,760 Added 1.86%	96,383 $25.1 Million
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $74.4 Million - $93.9 Million	-420,216 Reduced 81.62%	94,623 $20.8 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $2.29 Million - $2.56 Million	-12,600 Reduced 2.39%	514,839 $94.3 Million
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $80.7 Million - $95.1 Million	430,311 Added 443.03%	527,439 $106 Million
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $1.42 Million - $1.65 Million	6,845 Added 7.58%	97,128 $20.9 Million
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $655,186 - $873,824	3,165 Added 3.63%	90,283 $21.3 Million
Q3 2020 Oct 21, 2020	SELL	$255.65 - $303.1 $3.17 Million - $3.76 Million	-12,406 Reduced 12.47%	87,118 $23.7 Million
Q2 2020 Aug 10, 2020	SELL	$225.48 - $295.8 $349,268 - $458,194	-1,549 Reduced 1.53%	99,524 $28.9 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $4.9 Million - $6.07 Million	-24,504 Reduced 19.51%	101,073 $24.1 Million
Q4 2019 Feb 18, 2020	SELL	$166.71 - $223.91 $312,747 - $420,055	-1,876 Reduced 1.47%	125,577 $27.5 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $8.99 Million - $10.1 Million	-54,111 Reduced 29.8%	127,453 $21.6 Million
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $17.9 Million - $20.7 Million	-108,875 Reduced 37.49%	181,564 $33.3 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $70.7 Million - $84 Million	-431,610 Reduced 59.78%	290,439 $53.4 Million
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $25 Million - $31.6 Million	-164,557 Reduced 18.56%	722,049 $117 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $43.3 Million - $49.8 Million	-258,307 Reduced 22.56%	886,606 $171 Million
Q2 2018 Aug 09, 2018	BUY	$145.72 - $169.96 $118 Million - $137 Million	807,086 Added 238.91%	1,144,913 $195 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $25.8 Million - $30.2 Million	170,495 Added 101.89%	337,827 $55.1 Million
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $13.2 Million - $14.9 Million	95,825 Added 134.01%	167,332 $25.1 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $10.6 Million - $11.6 Million	71,507	71,507 $10.9 Million

Others Institutions Holding VRTX

# of Institutions

1,822

Shares Held

232M

Call Options Held

1.49M

Put Options Held

1.07M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $96.4B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account